Search

Displaying results 2541 - 2550 of 9886 in total
  1. Drug

    Ebrotidine

    go.drugbank.com/drugs/DB21220
    Experimental

    Ebrotidine has a monoisotopic molecular weight of 475.98 Da. … Ebrotidine is a small molecule drug. The usage of the INN stem '-tidine' in the name indicates that Ebrotidine is a histamine- H2​-receptor antagonist, cimetidine derivative.

  2. Drug

    Aloracetam

    go.drugbank.com/drugs/DB21233
    Experimental

    Aloracetam has a monoisotopic molecular weight of 208.12 Da. … Aloracetam is a small molecule drug. The usage of the INN stem '-racetam' in the name indicates that Aloracetam is a piracetam type amide type nootrope agent.

  3. Drug

    Oxmetidine

    go.drugbank.com/drugs/DB21430
    Experimental

    Oxmetidine has a monoisotopic molecular weight of 399.14 Da. … Oxmetidine is a small molecule drug. The usage of the INN stem '-tidine' in the name indicates that Oxmetidine is a histamine- H2​-receptor antagonist, cimetidine derivative.

  4. Drug

    Tisolagiline

    go.drugbank.com/drugs/DB21655
    Experimental

    Tisolagiline has a monoisotopic molecular weight of 322.13 Da. … Tisolagiline is a small molecule drug. The usage of the INN stem '-giline' in the name indicates that Tisolagiline is a monoamine oxydase (MAO)-inhibitor type B.

  5. Drug

    Mosperafenib

    go.drugbank.com/drugs/DB21673
    Experimental

    Mosperafenib has a monoisotopic molecular weight of 461.1 Da. … Mosperafenib is a small molecule drug. The usage of the INN stem '-rafenib' in the name indicates that Mosperafenib is a Raf (rapidly accelerated fibrosarcoma) kinase inhibitor.

  6. Drug

    Manitimus

    go.drugbank.com/drugs/DB06481
    Investigational

    FK778, a novel compound with multiple mechanisms of action, is efficacious, well tolerated and safe in kidney transplant patients, potentially offering a breakthrough in immunosuppressive therapy.

  7. Drug

    Salmon calcitonin

    go.drugbank.com/drugs/DB00017
    ApprovedInvestigational

    Synthetic peptide, 32 residues long formulated as a nasal spray.

    Products: Miacalcin Nasal Spray 200 Iu, MIACALCIC INJECTION 50 iu/ml
  8. Drug

    Foreskin keratinocyte (neonatal)

    go.drugbank.com/drugs/DB10772
    Approved

    To construct a "living" alternative, a dermal substitute based on collagen I gel was created with mesenchymal cells such as fibroblasts. … Keratinocytes are derived from neonatal foreskins and used to create a drug called _Apligraf_, a mixture of [DB10770] and keratinocytes.

  9. Drug

    Eliglustat

    go.drugbank.com/drugs/DB09039
    ApprovedInvestigational

    Eliglustat is a glucosylceramide synthase inhibitor used for the long-term treatment of type 1 Gaucher disease. … [A3752,L41404] Gaucher disease is a rare genetic disorder characterized by the deficiency of acid β-glucosidase, an enzyme that converts glucosylceramide into glucose and ceramide.

  10. Drug

    Fruquintinib

    go.drugbank.com/drugs/DB11679
    ApprovedInvestigational

    The first approach can be exemplified by [bevacizumab], a VEGF-A trap antibody. … Therefore, the advent of fruquintinib, a new generation of VEGFR inhibitors with a high kinome selectivity, demonstrated the feasibility of the small-molecule inhibitor approach.